Darifenacin
Product manufactured by Cipla Usa Inc.
Indications and Purposes
| 1 Indications And Usage Darifenacin Extended-Release Tablets Are Muscarinic Antagonist Indicated For The Treatment Of Overactive Bladder With Symptoms Of Urge Urinary Incontinence, Urgency And Frequency. ( 1 ) Darifenacin Extended-Release Tablets Are Muscarinic Antagonist Indicated For The Treatment Of Overactive Bladder With Symptoms Of Urge Urinary Incontinence, Urgency And Frequency. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Darifenacin Hydrobromide |
|
ZINC1996117 |